Trial Profile
Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase 2 : Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of WIN-901X in Asthma Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Dec 2013
Price :
$35
*
At a glance
- Drugs WIN 901X (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 01 Nov 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2013 New trial record